|
PRLD Prelude Therapeutics Inc 1678660 |
| Balance Sheet |
|
Current Assets
|
$84,593,000.00 |
|
Assets
|
$119,642,000.00 |
|
Current Liabilities
|
$41,720,000.00 |
|
Liabilities
|
$59,459,000.00 |
|
Equity
|
$60,183,000.00 |
|
Shares Out
|
79645307.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-21,685,000.00 |
|
Investing Cash Flow
|
$8,499,000.00 |
| Market Analysis |
Market Cap
|
$402,208,800.35 |
|
Price
|
$4.39 |
|
BVPS
|
0.76 |
|
PB
|
6.64 |
|
EPS
|
-0.13 |
|
PS
|
21.35 |
|
FCF
|
$-21,685,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:28 |
|
| Apr |
May |
Jun |
| 2026-03-10 |
-1.29 |
|
|
2026-05-12 |
-0.13 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.41 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.26 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PRLD documents filed with the SEC.
PRLD Filings
Clear
